Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Warram

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical modelsBenjamin B Kasten, Ke Jiang, Denzel Cole, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
Cancer Medicine|May 12, 2016
Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer modelsLindsay S Moore, Esther de Boer, Jason M Warram, et al.
Molecular Imaging and Biology|February 4, 2017
Fluorescence Imaging for Cancer Screening and SurveillanceK E Tipirneni, E L Rosenthal, L S Moore, et al.
Head & Neck|October 26, 2021
Hyperintensity of integrin-targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine greenMelanie D Hicks, Alyssa K Ovaitt, Jason C Fleming, et al.
Journal of Surgical Oncology|June 16, 2015
A ratiometric threshold for determining presence of cancer during fluorescence-guided surgeryJason M Warram, Esther de Boer, Lindsay S Moore, et al.
Plos One|February 19, 2020
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancerSindhu Nair, Hoa Q Trummell, Rajani Rajbhandari, et al.
Molecular Cancer Therapeutics|July 2, 2020
Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma MultiformeTiara S Napier, Neha Udayakumar, Aditi H Jani, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 29, 2025
Contemporary Status and Frontiers of Cervical Cancer Screening in the United StatesAbbigael V Eli, Benjamin B Kasten, Christopher M Mayer, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessmentJason M Warram, Esther de Boer, Gooitzen M van Dam, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical modelsBenjamin B Kasten, Ke Jiang, Denzel Cole, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
Cancer Medicine|May 12, 2016
Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer modelsLindsay S Moore, Esther de Boer, Jason M Warram, et al.
Molecular Imaging and Biology|February 4, 2017
Fluorescence Imaging for Cancer Screening and SurveillanceK E Tipirneni, E L Rosenthal, L S Moore, et al.
Head & Neck|October 26, 2021
Hyperintensity of integrin-targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine greenMelanie D Hicks, Alyssa K Ovaitt, Jason C Fleming, et al.
Journal of Surgical Oncology|June 16, 2015
A ratiometric threshold for determining presence of cancer during fluorescence-guided surgeryJason M Warram, Esther de Boer, Lindsay S Moore, et al.
Plos One|February 19, 2020
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancerSindhu Nair, Hoa Q Trummell, Rajani Rajbhandari, et al.
Molecular Cancer Therapeutics|July 2, 2020
Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma MultiformeTiara S Napier, Neha Udayakumar, Aditi H Jani, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 29, 2025
Contemporary Status and Frontiers of Cervical Cancer Screening in the United StatesAbbigael V Eli, Benjamin B Kasten, Christopher M Mayer, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessmentJason M Warram, Esther de Boer, Gooitzen M van Dam, et al.
Pageof 9